TAURUS-MS II: real-world use of teriflunomide in Germany and changes in treatment patterns over time

Autor: Boris-Alexander Kallmann, Georg zu Eulenburg, Jennifer S. Kullmann, Mathias Mäurer

Publikováno v: Therapeutic Advances in Neurological Disorders, Vol 17 (2024)

Background: Teriflunomide is a once-daily oral disease-modifying therapy (DMT) for the treatment of relapsing-remitting multiple sclerosis (RRMS). Only limited information is available about its real-world use and changes over time. Objectives: To co

Externí odkaz: https://doaj.org/article/c5d0af7140314f509c64980ade915ac2

Teriflunomide in relapsing-remitting multiple sclerosis: outcomes by age and pre-treatment status

Autor: Stefan Ries, Ulrich Engelmann, Jennifer S Kullmann, Boris Kallmann, Laura M Quint, Andrew T. Chan

Publikováno v: Kallmann, Boris A; Ries, Stefan; Kullmann, Jennifer S; Quint, Laura M; Engelmann, Ulrich; Chan, Andrew (2021). Teriflunomide in relapsing-remitting multiple sclerosis: outcomes by age and pre-treatment status. Therapeutic advances in neurological disorders, 14, p. 17562864211005588. Sage 10.1177/17562864211005588
Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
Therapeutic Advances in Neurological Disorders

Background and aims: To investigate effectiveness and safety of teriflunomide (14 mg once daily) in association with age and pre-treatment in unselected MS patients. Methods: Prespecified analysis of a non-interventional, prospective, real-world stud

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75354bdb730ef84846d2d7012b1034a2
https://boris.unibe.ch/157488/1/Kallmann__2021__Teriflunomide_in_relapsing_remitting_MS.pdf

Health-Related Quality of Life and the Relationship to Treatment Satisfaction in Patients with Multiple Sclerosis: Insights from a Large Observational Study

Autor: Tjalf Ziemssen, Rocco Haase, Dirk Schriefer, Jennifer S Kullmann

Publikováno v: Patient preference and adherence

Dirk Schriefer,1 Rocco Haase,1 Jennifer S Kullmann,2 Tjalf Ziemssen1 1University Clinic Carl Gustav Carus Dresden, Center of Clinical Neuroscience, Dresden, Germany; 2Sanofi-Aventis Deutschland GmbH, Neu-Isenburg, GermanyCorrespondence: Tjalf Ziemsse

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1533628ae8ba6a959550f98eaf5c7c7
https://www.dovepress.com/health-related-quality-of-life-and-the-relationship-to-treatment-satis-peer-reviewed-article-PPA

Neural response to emotional stimuli during experimental human endotoxemia

Autor: Christina Rosenberger, Reiner Oberbeck, Philipp Kobbe, Christina Banner, Philipp Lichte, Sigrid Elsenbruch, Jennifer S. Kullmann, Oliver T. Wolf, Jan-Sebastian Grigoleit, Elke R. Gizewski, Harald Engler, Michael Forsting, Manfred Schedlowski, Ulrike Bingel

Publikováno v: Human Brain Mapping. 34:2217-2227

Increases in peripheral cytokines during acute inflammation may affect various neuropsychological functions. The aim of this functional magnetic resonance imaging (fMRI) study was to investigate the effects of acute endotoxemia on mood and the neural

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::571ec5d17d9dcd283450696354d305f9
https://doi.org/10.1002/hbm.22063

Visceral sensitivity correlates with decreased regional gray matter volume in healthy volunteers: a voxel-based morphometry study

Autor: Nina Theysohn, Jennifer S. Kullmann, Joswin Kattoor, Julia Schmid, Michael Forsting, Sigrid Elsenbruch, Vassilios Kotsis

Publikováno v: PainReferences. 155(2)

Regional changes in brain structure have been reported in patients with altered visceral sensitivity and chronic abdominal pain, such as in irritable bowel syndrome. It remains unknown whether structural brain changes are associated with visceral sen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9747b8de2113955f600a21010db95429
https://pubmed.ncbi.nlm.nih.gov/24099953